US Patent Issued to IMCHECK THERAPEUTICS, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS-, INSTITUT JEAN PAOLI & IRENE CALMETTES, UNIVERSITE D'AIX-MARSEILLE on March 25 for "Antibodies having specificity for BTN2 and uses thereof" (French Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,400, issued on March 25, was assigned to IMCHECK THERAPEUTICS SAS (Marseilles, France), INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS- (Paris), INSTITUT JEAN PAOLI & IRENE CALMETTES (Marseilles, France) and UNIVERSITE D'AIX-MARSEILLE (Marseilles, France).

"Antibodies having specificity for BTN2 and uses thereof" was invented by Etienne Foucher (Marseilles, France), Carla Cano (Marseilles, France), Kieu Suong Le (Marseilles, France), Christine Pasero (Marseilles, France) and Daniel Olive (Marseilles, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present inven...